48 results on '"Wolden S"'
Search Results
2. Ethmoid Sinus Cancer: Experience and Oncological Outcomes at Memorial Sloan-Kettering Cancer Center (MSKCC): Non-Squamous Cell Malignancies of the Head and Neck (thyroid, skin cancers, salivary gland and sinus cancers)
3. Long-Term Outcomes of Definitive Radiation Therapy for Nasopharyngeal Carcinoma at a North American Institution: Definitive Management of Head-and-Neck Squamous Cell Carcinoma
4. Patterns of Failure in Patients With Head-and-Neck Carcinoma of Unknown Primary Treated With Radiation Therapy: Definitive Management of Head-and-Neck Squamous Cell Carcinoma
5. Sparing Low-Risk Nodes in Node-Positive (n+) Oropharyngeal Carcinoma (OPC) Improves Dysphagia Outcomes and Chronic PEG Rates
6. Sparing Bilateral Ib and Contralateral High Level II Nodes in Node-Positive (n+) Oropharyngeal Carcinoma (OPC) Improves Quality of Life on a Prospective Self-Reported Xerostomia Questionnaire
7. The Role of Postoperative PET/CT Imaging in Head-and-Neck Cancer Patients Prior to the Initiation of Adjuvant Radiation Therapy
8. Long-term Outcomes of Postoperative Radiation Therapy for Major Salivary Gland Tumors
9. Surgery Followed by Postoperative Radiation Therapy for Minor Salivary Gland Tumors
10. Definitive Photon Radiation Therapy in the Treatment of Unresectable Salivary Gland Tumors
11. Is IMRT Associated With Inferior Outcomes for T1-2N0 Squamous Cell Carcinoma of the Larynx?
12. Outcomes of Radiation Therapy for Hypopharyngeal Squamous Cell Carcinoma: A Single Institution Experience
13. Locoregional Patterns of Failure in Oropharyngeal Carcinoma: Implications for Treatment De-escalation
14. Surgery Improves Outcome in Recurrent Squamous Cell Carcinoma of the Oral Cavity
15. IMRT Versus Conventional Radiation Therapy for Postoperative Treatment of Oral Cavity Squamous Cell Carcinoma (OCSCC)
16. Can Meaningful and Durable Locoregional Control Be Achieved for Oral Cavity Squamous Cell Carcinoma (OCSCC) Treated With Definitive Radiation Therapy (RT)?
17. High-dose-rate (HDR) Intraoperative Brachytherapy and Radical Surgical Resection in the Management of Recurrent Head-and-Neck Cancer
18. Patterns of Failure (POF) After Salvage Reirradiation (re-RT) for Recurrent Head-and-Neck Cancer (HNC): Implications for Field Design and Consolidation Therapy
19. Predictive Factors for Locoregional Control After Salvage Reirradiation of Recurrent Head-and-Neck Cancer
20. Radiation Therapy for Chloroma (Granulocytic Sarcoma)
21. Subjective Hearing Loss (SHL) after Chemoradiation for Nasopharyngeal and Oropharyngeal Cancer Patients
22. Percutaneous Endoscopic Gastrostomy (PEG) in Oropharyngeal Cancer (OPC) Patients Treated with Intensity Modulated Radiotherapy (IMRT)
23. Neck Spasms as a Late Effect of Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancer
24. Mean Dose to Larynx as a Predictor of Late Dysphagia after Definitive Intensity Modulated Radiotherapy (IMRT) for Squamous Cell Carcinoma (SCC) of the Head and Neck
25. Constraining the Brachial Plexus Does Not Compromise Regional Control in Oropharyngeal Carcinoma
26. Long-term Regional Control in the Observed Neck following Definitive Chemoradiation for Node-positive Oropharyngeal Squamous Cell Cancer
27. Radiation Therapy in the Treatment of Angiosarcoma of the Head and Neck
28. Intensity Modulated Radiation Therapy (IMRT) for the Treatment of Oropharyngeal Carcinoma (OPC): Effect of Tumor Volume on Clinical Outcomes
29. Predicting Outcomes after Salvage Reirradiation of Recurrent Head and Neck Cancer
30. Target Volume Delineation in Oropharyngeal Cancer: Impact of PET, MRI and Physical Examination
31. Cisplatin (CDDP) and Radiation (RT) versus Cetuximab (C) and RT in the Context of Human Papillomavirus (HPV) and P16 in the Treatment of Locally Advanced Head and Neck Cancer (LAHNC)
32. A Retrospective Study of Re-irradiation (Re-RT) for Recurrent Medulloblastoma (MB)
33. Outcomes and Late Effects: A Comparison of Patients with Locally-advanced Head and Neck Cancer (LAHNC) Treated with Cisplatin (CDDP) and Radiation (RT) vs. Cetuximab (C) and RT
34. Hypofractionated Dose-painting Intensity Modulated Radiation Therapy (DP-IMRT) with Chemotherapy in the Treatment of Nasopharyngeal Carcinoma (NPC), a Prospective Trial
35. Post-Operative Radiotherapy in the Treatment of Paranasal Sinus and Nasal Cavity and Cancer
36. Treatment Results of 165 Pediatric Patients with Non-Metastatic Nasopharyngeal Carcinoma: A Rare Cancer Network Study
37. Evaluation of an intensity modulated radiation therapy treatment technique for patients with medulloblastoma
38. Influence of radiation therapy (RT) parameters on outcome in children treated for parameningeal rhabdomyosarcoma in the intergroup rhabdomyosarcoma group trials
39. 1038 Intensity modulated radiation therapy for primary nasopharynx cancer
40. Head and Neck Target Delineation among Radiation Oncology Residents after a Teaching Intervention: Feasibility and Preliminary Results
41. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
42. Using logical combinations of structures as a utility for inverse planning
43. Influence of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy
44. Re-irradiation of Locally Recurrent Nasopharyngeal Cancer
45. Post-operative Radiotherapy after Complete Surgical Resection for Head and Neck Mucosal Melanoma
46. Management of Adolescent Patients With Hodgkin's Disease in Cooperative Group Trials
47. 2372: Salvage Re-Irradiation for Recurrent Head and Neck Cancer
48. 2391: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Cancer of the Larynx/Hypopharynx
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.